Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-01-18
2011-01-18
Blanchard, David J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388230, C424S133100, C424S141100, C424S145100, C435S069600, C435S070210
Reexamination Certificate
active
07872102
ABSTRACT:
The present invention encompasses isolated antibodies, or antigen-binding portions thereof, that specifically bind to the p19 subunit of IL-23. These antibodies, or antigen-binding portions thereof, are high affinity, neutralizing antibodies useful for the treatment of autoimmune disease.
REFERENCES:
patent: 6060284 (2000-05-01), Bazan
patent: 6610285 (2003-08-01), Hirata
patent: WO 01/18051 (2001-03-01), None
Beidler Catherine Brautigam
Bright Stuart Willis
Dickinson Craig Duane
Kikly Kristine Kay
Marquis David Matthew
Blanchard David J.
Castetter Andrea M.
Eli Lilly and Company
LandOfFree
Anti-IL-23 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-IL-23 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-IL-23 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2638778